Back to funds

Ishara Investments LP

Updated 6 days ago

Managed by Ishara Investments Lp • Latest filing Q3 2026

Portfolio value
$121M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
98.8%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$87.5M
Q1 2026$105.6M
Q2 2026$136.1M
Q3 2026$121M

Top holdings

41 positions as of Q3 2026

View filing
T

TRAVERE THERAPEUTICS INC

Value
$8.5M
Shares
145.0K
% Port
7.06%
C

CYTOKINETICS INC

Value
$8.4M
Shares
128.0K
% Port
6.97%
B

BRIDGEBIO PHARMA INC

Value
$6.6M
Shares
100.0K
% Port
5.44%
A

ACADIA PHARMACEUTICALS INC

Value
$6.4M
Shares
320.0K
% Port
5.33%
T

TARSUS PHARMACEUTICALS INC

Value
$5.5M
Shares
70.0K
% Port
4.55%
P

PTC THERAPEUTICS INC

Value
$5.2M
Shares
80.0K
% Port
4.28%
P

PRAXIS PRECISION MEDICINES I

Value
$5M
Shares
17.0K
% Port
4.09%
V

VERA THERAPEUTICS INC

Value
$4.8M
Shares
150.0K
% Port
4.00%
A

ARCUTIS BIOTHERAPEUTICS INC

Value
$4.8M
Shares
180.0K
% Port
3.93%
A

ANNEXON INC

Value
$4.7M
Shares
1.12M
% Port
3.92%
U

UNITED THERAPEUTICS CORP DEL

Value
$4.3M
Shares
8.0K
% Port
3.58%
N

NEWAMSTERDAM PHARMA COMPANY

Value
$3.9M
Shares
160.0K
% Port
3.22%
X

XERIS BIOPHARMA HOLDINGS INC

Value
$3.8M
Shares
400.0K
% Port
3.16%
C

CELCUITY INC

Value
$3.8M
Shares
48.0K
% Port
3.15%
D

DBV TECHNOLOGIES S A

Value
$3.2M
Shares
270.0K
% Port
2.62%
V

VIRIDIAN THERAPEUTICS INC

Value
$3.1M
Shares
150.0K
% Port
2.55%
Z

ZENTALIS PHARMACEUTICALS INC

Value
$3M
Shares
1.08M
% Port
2.47%
B

BIOMARIN PHARMACEUTICAL INC

Value
$2.9M
Shares
48.0K
% Port
2.38%
B

BIOGEN INC

Value
$2.7M
Shares
12.0K
% Port
2.24%
M

MINERALYS THERAPEUTICS INC

Value
$2.5M
Shares
100.0K
% Port
2.08%

Explore